Reply to: Enzalutamide after failure of docetaxel and abiraterone in metastatic castrate resistant prostate cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： David,Lorente

第一单位： The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom.

作者： David,Lorente ^[1] ; Diletta,Bianchini ^[1] ; Alejo,Rodriguez-Vida ^[2] ; Aurelius,Omlin ^[1] ; Carmel,Pezaro ^[1] ; Roberta,Ferraldeschi ^[1] ; Andrea,Zivi ^[1] ; Gerhardt,Attard ^[1] ; Simon,Chowdhury ^[2] ; Johann S,De Bono ^[3]

作者单位： The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom. ^[1] Guy's and St. Thomas NHS Foundation Trust, United Kingdom. ^[2] The Institute of Cancer Research & The Royal Marsden NHS Foundation Trust, United Kingdom. Electronic address: Johann.De-Bono@icr.ac.uk. ^[3]

主题词雄甾烯醇类(Androstenols);人类(Humans);男(雄)性(Male);苯硫乙内酰脲(Phenylthiohydantoin);紫杉烷类(Taxoids)

DOI 10.1016/j.ejca.2013.12.016

PMID 24433842

发布时间 2022-01-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交